Literature DB >> 25712181

Expansion of pharmacogenomics into the community pharmacy: billing considerations.

Shanna K O'Connor1, Natasha Michaels, Stefanie Ferreri.   

Abstract

Keywords:  billing; community pharmacy; pharmacogenomics; reimbursement

Mesh:

Year:  2015        PMID: 25712181     DOI: 10.2217/pgs.14.183

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  5 in total

1.  Advancing Pharmacogenomics as a Component of Precision Medicine: How, Where, and Who?

Authors:  J A Johnson; K W Weitzel
Journal:  Clin Pharmacol Ther       Date:  2015-11-09       Impact factor: 6.875

2.  Approaches to assessing the provider experience with clinical pharmacogenomic information: a scoping review.

Authors:  Nicholas J Keeling; Tyler J Dunn; John P Bentley; Sujith Ramachandran; James M Hoffman; Meagen Rosenthal
Journal:  Genet Med       Date:  2021-04-29       Impact factor: 8.822

3.  Transitioning Pharmacogenomics into the Clinical Setting: Training Future Pharmacists.

Authors:  Amber Frick; Cristina S Benton; Kelly L Scolaro; Jacqueline E McLaughlin; Courtney L Bradley; Oscar T Suzuki; Nan Wang; Tim Wiltshire
Journal:  Front Pharmacol       Date:  2016-08-08       Impact factor: 5.810

Review 4.  Pharmacogenomics in the United States Community Pharmacy Setting: The Clopidogrel-CYP2C19 Example.

Authors:  David F Kisor; Natasha J Petry; David R Bright
Journal:  Pharmgenomics Pers Med       Date:  2021-05-18

5.  Development of Customizable Implementation Guides to Support Clinical Adoption of Pharmacogenomics: Experiences of the Implementing GeNomics In pracTicE (IGNITE) Network.

Authors:  Benjamin Q Duong; Meghan J Arwood; J Kevin Hicks; Amber L Beitelshees; Francesco Franchi; John T Houder; Nita A Limdi; Kelsey J Cook; Aniwaa Owusu Obeng; Natasha Petry; Sony Tuteja; Amanda R Elsey; Larisa H Cavallari; Kristin Wiisanen
Journal:  Pharmgenomics Pers Med       Date:  2020-07-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.